Bisschop, Cornelis <br/><br/>
Association Between Pembrolizumab-related Adverse Events and Treatment Outcome in Advanced Melanoma: Results From the Dutch Expanded Access Program.  [electronic resource] 

 -  Journal of immunotherapy (Hagerstown, Md. : 1997)   
 - 208-214 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1537-4513 
<br/><br/><label>Standard No.: </label>10.1097/CJI.0000000000000271  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal, Humanized--adverse effects<br/>Antineoplastic Agents, Immunological--adverse effects<br/>Clinical Trials as Topic<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Male<br/>Melanoma--drug therapy<br/>Neoplasm Staging<br/>Netherlands<br/>Proportional Hazards Models<br/>Treatment Outcome